H. pylori can both increase and decrease stomach acid, depending on where in the stomach the infection takes hold. An infection concentrated in the lower part of the stomach (the antrum) typically drives acid levels up, while an infection that spreads to the main body of the stomach (the corpus) gradually suppresses acid production. This dual effect explains why H. pylori is linked to both ulcers and stomach cancer, two conditions with very different acid profiles.
Why Location in the Stomach Matters
Your stomach has distinct zones that play different roles in acid production. The antrum, near the bottom, contains hormone-producing cells that regulate how much acid the rest of the stomach makes. The corpus, the large central body, contains the acid-producing cells themselves. When H. pylori colonizes one zone more heavily than the other, the effect on acid output diverges sharply.
In antrum-predominant infections, acid goes up. In corpus-predominant infections, acid goes down. Most people with H. pylori have some degree of inflammation in both areas, but the dominant pattern determines the clinical outcome. This is why two people with the same bacterium can develop completely different problems.
How H. Pylori Raises Acid
When H. pylori settles mainly in the antrum, it disrupts a feedback loop that normally keeps acid production in check. The antrum contains two key cell types that work as a pair: G cells, which release the hormone gastrin to stimulate acid, and D cells, which release a braking hormone called somatostatin to keep gastrin in check. H. pylori reduces the number and function of D cells, likely through the inflammation it triggers and through the ammonia its enzymes produce, which creates a localized alkaline environment.
With fewer D cells applying the brakes, G cells release gastrin unchecked. Gastrin levels in the blood rise, and the acid-producing cells in the corpus respond by pumping out more acid. This pattern of excess acid is what makes antrum-predominant H. pylori infection a major driver of duodenal ulcers, which form in the first part of the small intestine where the acidic stomach contents empty out.
How H. Pylori Lowers Acid
When the infection spreads into or primarily affects the corpus, the dynamic reverses. The corpus is where acid-producing parietal cells live, and inflammation there directly interferes with their ability to function. H. pylori suppresses the molecular pumps these cells use to secrete acid, and immune cells that flood the area release signaling molecules that further inhibit acid output.
Interestingly, early in a corpus infection, the parietal cells are still present in normal numbers. They aren’t destroyed right away; they’re just not working properly. Over years or decades, however, chronic inflammation can progress to atrophic gastritis, where the acid-producing lining gradually thins and is replaced by tissue that resembles the intestinal lining. At this stage, acid production drops significantly and sometimes nearly ceases. Research published in the corpus gastritis literature shows a clear inverse relationship: the more severe the chronic inflammation in the corpus, the lower the peak acid output.
What Determines Which Pattern You Get
Several factors influence whether an infection stays in the antrum or spreads to the corpus. Genetics play a role, particularly genes that govern the intensity of your immune response. People who mount a stronger inflammatory response to the bacterium tend to develop more corpus involvement and, over time, lower acid levels. Environmental factors like diet, smoking, and salt intake also contribute. The specific strain of H. pylori matters too, as some strains are more virulent and more likely to cause widespread inflammation.
In populations where antrum-predominant infection is common, duodenal ulcers are the typical outcome. In populations where corpus-predominant infection prevails, the long-term risk shifts toward stomach cancer. A landmark study in the New England Journal of Medicine confirmed that patients with severe atrophic gastritis, corpus-predominant inflammation, and intestinal metaplasia (the replacement of normal stomach lining) are at high risk for a type of stomach cancer called intestinal-type gastric adenocarcinoma.
Baseline pH May Look Normal on Testing
One counterintuitive finding is that standard pH measurements in people with H. pylori don’t always look dramatically different from those without it. In one study measuring 24-hour pH, median values in H. pylori-positive subjects were 1.5 in the corpus and 1.3 in the antrum, compared to 1.4 and 1.2 in uninfected subjects. Those differences were not statistically significant.
The distinction becomes more apparent under specific conditions. When the same subjects took a proton pump inhibitor (a common acid-suppressing medication), those with H. pylori had significantly higher pH levels: 5.5 in both the corpus and antrum, compared to 4.0 and 3.5 in uninfected subjects. This means H. pylori amplifies the acid-suppressing effect of these medications, which has practical implications if you’re taking them for reflux or ulcers.
What Happens to Acid After Treatment
A common concern is whether eliminating H. pylori causes a rebound in acid production, particularly in people whose infection had been suppressing it. The logic is straightforward: if the bacterium was dampening acid output, removing it should let acid levels rise, potentially triggering or worsening reflux symptoms.
The clinical reality is more reassuring than the theory suggests. A 2025 prospective study of 248 patients with gastroesophageal reflux disease found that those who had H. pylori eradicated actually experienced lower rates of symptom rebound (19.8%) compared to reflux patients without the infection (34.2%). The severity of any rebound symptoms was also milder in the eradication group. This suggests that for most people, successfully treating H. pylori does not create a significant new acid problem.
That said, the recovery of acid production after eradication can vary. In people with mild corpus inflammation, acid-producing cells typically return to normal function within weeks to months. In people with established atrophic gastritis, the damage may be partially or fully irreversible, meaning acid levels can remain low even after the bacterium is gone. The degree of recovery depends largely on how far the inflammation had progressed before treatment.
Why This Matters for Symptoms
Understanding which direction your acid has shifted helps explain symptoms that might otherwise seem contradictory. If you have antrum-predominant H. pylori with high acid, you’re more likely to experience burning upper abdominal pain, especially on an empty stomach, and symptoms that improve with eating. If you have corpus-predominant infection with low acid, you might notice bloating, early fullness, nausea, or poor digestion of protein-heavy meals, since adequate acid is needed to break down food and activate digestive enzymes.
Low stomach acid also impairs absorption of certain nutrients, particularly iron, calcium, and vitamin B12, because acid is required to release these from food. Prolonged low acid from atrophic gastritis can lead to deficiencies over time, even with a normal diet. This is one of the less obvious but clinically important consequences of long-standing H. pylori infection in the corpus.